(Q33939122)

English

Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

object named as

Sudhesh Kumar

13

0 references

Christine M Kusminski

6

object named as

Christine M Kusminski

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Kirsty C McGee

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Alison L Harte

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Nancy F da Silva

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Nasser Al-Daghri

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Steven J Creely

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gyanendra Tripathi

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Paul L Levick

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Manish Khanolkar

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Marc Evans

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Madhu V Chittari

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Vinod Patel

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Philip G McTernan

14

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

9 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

e20287

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

copyright license

Creative Commons Attribution 4.0 International

9 June 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Autocrine effects of visfatin on hepatocyte sensitivity to insulin action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

5 July 2018

Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

The release of the adipocytokine visfatin is regulated by glucose and insulin.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Visfatin is an adipokine, but it is not regulated by thiazolidinediones

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Pre-B-cell colony-enhancing factor (PBEF/Visfatin) gene expression is modulated by NF-kappaB and AP-1 in human amniotic epithelial cells.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020287

21 January 2018

Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111427

29 October 2018

Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/21694775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21694775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21694775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/21694775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free fatty acids normalize a rosiglitazone-induced visfatin release

1 reference

https://pubmed.ncbi.nlm.nih.gov/21694775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visfatin concentration in Asian Indians is correlated with high density lipoprotein cholesterol and apolipoprotein A1

1 reference

https://pubmed.ncbi.nlm.nih.gov/21694775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like effects of visfatin on human osteoblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/21694775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum concentration of visfatin in obese women

1 reference

https://pubmed.ncbi.nlm.nih.gov/21694775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating visfatin level is correlated with inflammation, but not with insulin resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/21694775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/21694775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21694775

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0020287

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2011PLoSO...620287M

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33939122&oldid=1869237990"